LORD ABBETT BALANCED STRATEGY FUND CLASS C (BFLAX US) stock market data APIs
11.9701
0(0%)
as of April 29, 2025
LORD ABBETT BALANCED STRATEGY FUND CLASS C Financial Data Overview
Prev. Close
11.9701
Open
11.9701
High
11.9701
Low
11.9701
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get LORD ABBETT BALANCED STRATEGY FUND CLASS C data using free add-ons & libraries
End-of-day & Earnings data
Get LORD ABBETT BALANCED STRATEGY FUND CLASS C Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get LORD ABBETT BALANCED STRATEGY FUND CLASS C End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
LORD ABBETT BALANCED STRATEGY FUND CLASS C News
New
RedHill to Present at Upcoming Conferences in March
TEL AVIV, Israel and RALEIGH, NC, March 5, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it will ...
RedHill to Present at Upcoming Conferences in March
TEL AVIV, Israel and RALEIGH, NC, March 5, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it will ...
RedHill Biopharma Announces Closing of $35 Million Bought Deal Offering of American Depositary Shares
TEL AVIV, Israel and RALEIGH, N.C., March 4, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the closing...
ObvioHealth and RedHill Biopharma Launch First in Kind Remote COVID-19 Therapy Trial Incorporating Highest Level of At-home Patient Monitoring to Date
NEW YORK, March 2, 2021 /PRNewswire/ -- ObvioHealth, a global virtual research organization or VRO, today announced the launch of a hybrid clinical trial for the treatment of COVID-19, using an innova...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
